1. Home
  2. MSD vs TMCI Comparison

MSD vs TMCI Comparison

Compare MSD & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley Emerging Markets Debt Fund Inc.

MSD

Morgan Stanley Emerging Markets Debt Fund Inc.

HOLD

Current Price

$7.30

Market Cap

149.4M

Sector

Finance

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.48

Market Cap

174.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSD
TMCI
Founded
1993
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.4M
174.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MSD
TMCI
Price
$7.30
$2.48
Analyst Decision
Hold
Analyst Count
0
6
Target Price
N/A
$6.87
AVG Volume (30 Days)
70.2K
777.8K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
11.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$218,879,000.00
Revenue This Year
N/A
$3.25
Revenue Next Year
N/A
$1.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.90
52 Week Low
$6.11
$2.44
52 Week High
$7.46
$10.79

Technical Indicators

Market Signals
Indicator
MSD
TMCI
Relative Strength Index (RSI) 41.87 25.73
Support Level $7.35 $2.44
Resistance Level $7.46 $2.76
Average True Range (ATR) 0.04 0.19
MACD 0.00 0.09
Stochastic Oscillator 0.29 4.81

Price Performance

Historical Comparison
MSD
TMCI

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: